ArticleAdvances in therapy2025

Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).

Alan P Baptist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.